Published in Obesity and Diabetes Week, August 29th, 2005
Current treatments for wet macular degeneration have demonstrated limited efficacy to date and require injection into the eye, thus increasing the risk of infection and retinal detachment.
Pre-clinical studies conducted to date with TG100801 have shown...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week